News Shire launches potential blockbuster dry eye drug in US Xiidra could be ophthalmology blockbuster.
News Genzyme and AZ fall foul of UK pharma code Companies named in adverts after breaching code of practice.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
